Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Nov 23, 2022
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices and funding opportunities:
Policy Notices
- Reminder to AHRQ Grantees that FY2018 Funds will Expire on September 30, 2023
(NOT-HS-23-002)
Agency for Healthcare Research and Quality
- AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research
(NOT-HS-23-003)
Agency for Healthcare Research and Quality
- This Notice is to expire PA-20-068 "Improving Quality of Care and Patient Outcomes During Care Transitions (R01)"
(NOT-HS-23-004)
Agency for Healthcare Research and Quality
General Notices
- Notice to Extend the Response Date for NOT-AR-22-023 "Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029"
(NOT-AR-23-007)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of Technical Assistance Webinar for Potential Applicants to RFA-CA-23-013, Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
(NOT-CA-23-013)
National Cancer Institute
- Notice RFA-DK-22-010 "Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)" Is Being Reissued
(NOT-DK-23-001)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice RFA-DK-22-015 Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed) is Being Reissued
(NOT-DK-23-002)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of a Question and Answer "Office Hour" with NIGMS Staff for IMSD and G-RISE Applicants
(NOT-GM-23-020)
National Institute of General Medical Sciences
- Notice of Information on NIMH's Considerations for Research Involving Psychedelics and Related Compounds
(NOT-MH-23-125)
National Institute of Mental Health
- Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
(NOT-OD-23-019)
Office of the Director, NIH
- Human Subjects Research: Policies, Inclusion, & Clinical Trials Free 2-Day Virtual Event with NIH & HHS Experts December 6-7, 2022
(NOT-OD-23-021)
National Institutes of Health
- Notice of Future Research Opportunity Announcement for All of Us Research Participant and Partner Services Center
(NOT-PM-23-001)
Office of the Director, NIH
- Request for Information: Soliciting Public Comment on Draft Amyotrophic Lateral Sclerosis (ALS) Strategic Plan
(NOT-NS-23-041)
National Institute of Neurological Disorders and Stroke
Notice of Changes to Funding Opportunities
- Notice of NIAMS Participation in PAR-20-089, "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)"
(NOT-AR-23-010)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of NIAMS Participation in PAR-20-097, "Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)"
(NOT-AR-23-011)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Notice of Change to Application Due Dates and deletion of the Introduction to Application Section for RFA-DK-22-019
(NOT-DK-23-003)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Early Expiration of RFA-HG-21-001, Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial Not Allowed)" & RFA-HG-21-002, Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial Not Allowed)"
(NOT-HG-23-013)
National Human Genome Research Institute
- Notice of Change in Page Limitations for PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)"
(NOT-HL-22-056)
National Heart, Lung, and Blood Institute
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed)
(NOT-DA-22-064)
National Institute on Drug Abuse
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Entry-Level Modules (ELM) for Training the Genomics Research Workforce (UE5-Clinical Trial Not Allowed)
(NOT-HG-23-014)
National Human Genome Research Institute
- Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
(NOT-MH-23-135)
National Institute of Mental Health
- Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
(NOT-MH-23-136)
National Institute of Mental Health
Notices of Special Interest
- Notice of Special Interest (NOSI): Administrative Supplement for NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
(NOT-CA-23-012)
National Cancer Institute
- Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment
(NOT-DA-24-002)
National Institute on Drug Abuse
- Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
(NOT-OD-23-002)
Office of the Director, NIH
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of General Medical Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of Research on Women's Health
- Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
(NOT-OD-23-018)
Office of the Director, NIH
John E. Fogarty International Center
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Cancer Institute
National Eye Institute
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute on Aging
National Institute on Alcohol Abuse and Alcoholism
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute on Minority Health and Health Disparities
National Institute of Neurological Disorders and Stroke
National Institute of Nursing Research
National Library of Medicine
Office of Research on Women's Health
Funding Opportunities
- Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
(PAR-24-022)
National Institute of Biomedical Imaging and Bioengineering
National Eye Institute
National Institute on Aging
- Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
(RFA-AI-22-069)
National Institute of Allergy and Infectious Diseases
- HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional)
(RFA-DA-23-059)
National Institute on Drug Abuse
National Center for Complementary and Integrative Health
National Institute on Alcohol Abuse and Alcoholism
- HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional)
(RFA-DA-23-060)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
- Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
(RFA-DA-24-002)
National Institute on Drug Abuse
- Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
(RFA-DK-23-002)
National Institute of Diabetes and Digestive and Kidney Diseases
National Heart, Lung, and Blood Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
(RFA-DK-23-003)
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute on Minority Health and Health Disparities
National Institute of Nursing Research
Office of Disease Prevention
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu(link sends e-mail) or 313-335-2123, or email Ann Ricketts at ann-ricketts@uiowa.edu(link sends e-mail) or Lynn Hudachek at lynn-hudachek@uiowa.edu(link sends e-mail).